Cornerstone Planning Group LLC Alkermes Plc. Transaction History
Cornerstone Planning Group LLC
- $418 Billion
- Q1 2025
A detailed history of Cornerstone Planning Group LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 11 shares of ALKS stock, worth $292. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11
Previous 11
-0.0%
Holding current value
$292
Previous $347,000
13.83%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ALKS
# of Institutions
407Shares Held
177MCall Options Held
229KPut Options Held
436K-
Black Rock Inc. New York, NY29.1MShares$774 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$484 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.8MShares$314 Million0.05% of portfolio
-
State Street Corp Boston, MA8.02MShares$213 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY6.88MShares$183 Million3.72% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.37B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...